Drug intelligence / Profile preview

IKC-151V

Development stage
Preclinical
Lead developer
ikarovec
Modality
AAV Vectors → Viral Vectors → Gene Addition/Replacement → Gene Therapies
Administration
Intravitreal, Ophthalmic
01

Overview

IKC-151V is a gene therapy drug developed by Ikarovec Ltd. It is a bi-cistronic vector designed to treat retinal conditions associated with significant vascular remodeling, particularly wet age-related macular degeneration (wet-AMD). The drug has demonstrated the ability to reverse neovascularization in murine AMD models. Research suggests that IKC-151V gene therapy can reverse vascular changes occurring during neovascular AMD (nAMD), with findings indicating that connective tissue growth factor (CTGF) plays a role in its mechanism of action. The drug is currently in preclinical development stage.

02

Targets

FCGR1A (High affinity immunoglobulin gamma fc receptor I)CTGF (Connective tissue growth factor)VEGFA (Vascular endothelial growth factor A)FCGRT (Neonatal crystallizable fragment receptor)

Beyond the preview

Go deeper on IKC-151V.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on IKC-151V.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call